Nath Bio-Genes (India) Limited (NATHBIOGEN) — Corporate Governance | 6 August 2026

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
SEBI appoints CNK & Associates LLP as forensic auditor for Nath Bio-Genes
🔄 What Changed
Forensic audit initiated covering FY2020-21 to FY2025-26
💡 Investor Takeaway
The forensic audit may uncover governance or financial irregularities affecting the company's reputation and valuation.

Nath Bio-Genes (India) Limited disclosed on August 6, 2026 that SEBI appointed CNK & Associates LLP as forensic auditor to examine its financial records from 2020-21 to 2025-26 following regulatory concerns. The company confirmed full cooperation with the audit and reiterated its commitment to governance standards amid ongoing compliance scrutiny.

📄 View Original Announcement (PDF)

About Nath Bio-Genes (India) Limited (NATHBIOGEN)

Fast Moving Consumer Goods · FMCG · Listed on NSE

Market Cap: ₹289.43 Cr P/E: 7.8 ROE: 6.0% ROCE: 7.9% Div Yield: 1.31%

View full NATHBIOGEN stock details →

📡 Get AI alerts when NATHBIOGEN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track NATHBIOGEN — Free

📊 More NATHBIOGEN filings

See all NATHBIOGEN filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when NATHBIOGEN files new disclosures

Track NATHBIOGEN filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track NATHBIOGEN — Free

Free account · 2 AI queries/day